Intangible assets (goodwill)
x € 1,000
2023 |
2022 |
|
Carrying amount |
||
Balance at 1 January |
21,207 |
21,207 |
Balance at 31 December |
21,207 |
21,207 |
Intangible assets comprise goodwill purchased on the acquisition of IBC in 2001. Historical cost was € 47.2 million and accumulated impairment was € 26 million.
Financial assets
x € 1,000
2023 |
2022 |
|
Investments in Group companies |
452,855 |
92,990 |
Loans granted to group companies |
481,035 |
491,752 |
Deferred tax asset |
12,529 |
20,727 |
Total financial assets |
946,419 |
605,469 |
Investments in Group companies
x € 1,000
2023 |
2022 |
|
Balance at 1 January |
92,990 |
32,501 |
Share in results of investees after tax |
66,705 |
60,533 |
Capital contribution |
296,873 |
0 |
Changes in actuarial results relating to employee benefits |
-3,713 |
-44 |
Balance at 31 December |
452,855 |
92,990 |
Set off against receivables from Group companies |
0 |
0 |
Recognised under financial assets |
452,855 |
92,990 |
The investments in Group companies are direct or indirect interests in them. The principal Group companies are listed in section 7 of the consolidated financial statements. For the acquisition of investees, see note 6.2 Business combinations.
Loans granted to group companies
x € 1,000
31 December 2023 |
31 December 2022 |
|
Balance at 1 January |
491,752 |
499,399 |
Loans granted |
16,154 |
36,321 |
Loans repaid |
-26,871 |
-43,968 |
Balance at 31 December |
481,035 |
491,752 |
Loans granted to group companies predominantly have a maturity of more than one year.
Deferred tax assets
Deferred tax assets relate to losses of the Heijmans N.V. tax group which have been recognised but not yet utilised. The movements in the financial year were as follows:
x € 1,000
2023 |
2022 |
|
Balance at 1 January |
20,727 |
25,509 |
Effect of changes in the tax rate |
0 |
0 |
Prior-year adjustment |
-210 |
-23 |
Charge for the financial year |
-8,011 |
-9,183 |
Recognition of previously unrecognised losses |
23 |
4,424 |
Impact of new loss relief rules |
0 |
0 |
Balance at 31 December |
12,529 |
20,727 |
See note 6.15 to the consolidated financial statements for details of the deferred tax asset relating to losses of the Heijmans N.V tax group that have not yet been utilised.
Cash and cash equivalents
Cash balances are at the free disposal of the Company.
Equity
2023 |
Issued capital |
Share premium reserve |
Statutory reserve for investees |
Reserve for actuarial results |
Reserve for Bonus Investment Share Matching Plan |
Retained earnings |
Result for the year after tax |
Total Equity |
Balance at 1 January |
7,066 |
266,739 |
19,259 |
-60,259 |
310 |
24,324 |
59,580 |
317,019 |
Share issue |
690 |
22,745 |
0 |
0 |
0 |
0 |
0 |
23,435 |
Dividend payments |
292 |
10,731 |
0 |
0 |
0 |
-23,787 |
0 |
-12,764 |
Reclassification |
0 |
0 |
17,000 |
0 |
0 |
-17,000 |
0 |
0 |
Bonus Investment Share Matching Plan |
0 |
0 |
0 |
0 |
-53 |
0 |
0 |
-53 |
Appropriation of result for 2022 |
0 |
0 |
0 |
0 |
0 |
59,580 |
-59,580 |
0 |
Total result |
0 |
0 |
0 |
-3,713 |
0 |
0 |
59,733 |
56,020 |
Balance at 31 December |
8,048 |
300,215 |
36,259 |
-63,972 |
257 |
43,117 |
59,733 |
383,657 |
2022 |
Issued capital |
Share premium reserve |
Statutory reserve for investees |
Reserve for actuarial results |
Reserve for Bonus Investment Share Matching Plan |
Retained earnings |
Result for the year after tax |
Total Equity |
Balance at 1 January |
6,828 |
257,018 |
29,859 |
-60,214 |
340 |
-16,545 |
50,299 |
267,585 |
Share issue |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Dividend payments |
238 |
9,721 |
0 |
0 |
0 |
-20,030 |
0 |
-10,071 |
Reclassification |
0 |
0 |
-10,600 |
0 |
0 |
10,600 |
0 |
0 |
Bonus Investment Share Matching Plan |
0 |
0 |
0 |
0 |
-30 |
0 |
0 |
-30 |
Appropriation of result for 2022 |
0 |
0 |
0 |
0 |
0 |
50,299 |
-50,299 |
0 |
Total result |
0 |
0 |
0 |
-44 |
0 |
0 |
59,580 |
59,536 |
Balance at 31 December |
7,066 |
266,739 |
19,259 |
-60,258 |
310 |
24,324 |
59,580 |
317,020 |
Authorised share capital
Composition of the authorised share capital is as follows:
in € |
31 December 2023 |
31 December 2022 |
35,100,000 ordinary shares, each with a nominal value of €0.30 |
10,530,000 |
10,530,000 |
4,900,000 cumulative financing preference shares B, each with a nominal value of €0.30 |
1,470,000 |
0 |
7,000,000 cumulative financing preference shares B, each with a nominal value of €0.21 |
0 |
1,470,000 |
8,000,000 protective preference shares, each with a nominal value of €1.50 |
12,000,000 |
12,000,000 |
24,000,000 |
24,000,000 |
As at 31 December 2023, the number of ordinary shares issued stood at 26,826,860 (2022: 23,552,926). All the outstanding shares are paid up, which represents a value of € 8,047,758 (at € 0.30 per share) (2022: 7,065,877.80 at € 0.30 per share). Depositary receipts are issued for ordinary shares. Holders of depositary receipts have the option to convert these into shares under certain conditions. This option has been exercised for seven depositary receipts. The holders of ordinary shares or their depositary receipts are entitled to dividend and have the right to exercise 30 votes per share at meetings of the Company’s shareholders.
Share premium reserve
The share premium reserve consists of the capital paid up in excess of the nominal value.
Reserve for investees
The statutory reserve for investees represents the difference between the retained earnings and the direct changes in equity as calculated using the parent company’s accounting policies on the one hand and that portion for which the parent company can determine distribution on the other hand. The statutory reserve is determined for each investee individually. This reserve is not freely distributable.
Reserve for actuarial results
The reserve for actuarial results represents the actuarial results on employee-benefits (see note 6.23 to the consolidated financial statements).
Reserve for Bonus Investment Share Matching Plan
For information on the reserve for the Bonus Investment Share Matching Plan, see note 6.29 to the consolidated financial statements.
Appropriation of result
It is proposed to distribute 40% of the result after tax, of € 60 million, as dividend on ordinary shares of their depository receipts and to add the remainder to the reserves, as stated in the ‘11.1 Appropriation of results’ section of this report.
Payables
x € 1,000
31 December 2023 |
31 December 2022 |
|
Non-current liabilities |
||
Linear loan |
55,000 |
0 |
55,000 |
0 |
|
Current liabilities |
||
Group companies |
388,267 |
344,481 |
Linear loan |
20,000 |
0 |
Syndicated bank financing |
146,435 |
0 |
Other liabilities |
2,557 |
482 |
557,259 |
344,963 |